| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen | 2.53e-03 | 194 | 8 | 2 | GO:0016705 | |
| GeneOntologyBiologicalProcess | regulation of double-strand break repair via nonhomologous end joining | 6.49e-05 | 32 | 8 | 2 | GO:2001032 | |
| GeneOntologyBiologicalProcess | double-strand break repair via nonhomologous end joining | 3.80e-04 | 77 | 8 | 2 | GO:0006303 | |
| GeneOntologyBiologicalProcess | response to type II interferon | 1.26e-03 | 141 | 8 | 2 | GO:0034341 | |
| GeneOntologyBiologicalProcess | regulation of double-strand break repair | 1.35e-03 | 146 | 8 | 2 | GO:2000779 | |
| GeneOntologyBiologicalProcess | biomineral tissue development | 2.60e-03 | 203 | 8 | 2 | GO:0031214 | |
| GeneOntologyBiologicalProcess | regulation of DNA repair | 3.43e-03 | 234 | 8 | 2 | GO:0006282 | |
| GeneOntologyBiologicalProcess | double-strand break repair | 6.47e-03 | 324 | 8 | 2 | GO:0006302 | |
| HumanPheno | Abdominal wall muscle weakness | 3.14e-05 | 17 | 3 | 2 | HP:0009023 | |
| Domain | - | 3.80e-02 | 746 | 8 | 2 | 3.40.50.300 | |
| Pathway | REACTOME_DISEASES_OF_METABOLISM | 4.48e-03 | 250 | 6 | 2 | M27554 | |
| Interaction | LCA5L interactions | 5.96e-05 | 30 | 8 | 2 | int:LCA5L | |
| Coexpression | BLANCO_MELO_COVID19_BRONCHIAL_EPITHELIAL_CELLS_SARS_COV_2_INFECTION_UP | 8.21e-04 | 144 | 8 | 2 | M34020 | |
| Coexpression | GSE10147_IL3_VS_IL3_AND_CPG_STIM_PDC_UP | 8.67e-04 | 148 | 8 | 2 | M348 | |
| Coexpression | GSE43863_NAIVE_VS_MEMORY_TH1_CD4_TCELL_D150_LCMV_UP | 1.41e-03 | 189 | 8 | 2 | M9722 | |
| Coexpression | GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_14H_DN | 1.45e-03 | 192 | 8 | 2 | M4277 | |
| Coexpression | GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_16H_DN | 1.50e-03 | 195 | 8 | 2 | M4279 | |
| Coexpression | GSE14000_UNSTIM_VS_4H_LPS_DC_TRANSLATED_RNA_DN | 1.53e-03 | 197 | 8 | 2 | M3338 | |
| Coexpression | GSE2706_UNSTIM_VS_8H_LPS_DC_DN | 1.54e-03 | 198 | 8 | 2 | M4701 | |
| Coexpression | GSE7400_CTRL_VS_CSF3_IN_VIVO_TREATED_PBMC_DN | 1.54e-03 | 198 | 8 | 2 | M5670 | |
| Coexpression | GSE40685_TREG_VS_FOXP3_KO_TREG_PRECURSOR_DN | 1.56e-03 | 199 | 8 | 2 | M9308 | |
| Coexpression | GSE43955_1H_VS_10H_ACT_CD4_TCELL_WITH_TGFB_IL6_UP | 1.56e-03 | 199 | 8 | 2 | M9674 | |
| Coexpression | GSE11961_GERMINAL_CENTER_BCELL_DAY7_VS_GERMINAL_CENTER_BCELL_DAY40_UP | 1.56e-03 | 199 | 8 | 2 | M9330 | |
| Coexpression | GSE27786_CD8_TCELL_VS_NKTCELL_DN | 1.57e-03 | 200 | 8 | 2 | M4840 | |
| Coexpression | GSE41087_WT_VS_FOXP3_MUT_ANTI_CD3_CD28_STIM_CD4_TCELL_DN | 1.57e-03 | 200 | 8 | 2 | M9528 | |
| Coexpression | GSE43955_1H_VS_42H_ACT_CD4_TCELL_DN | 1.57e-03 | 200 | 8 | 2 | M9665 | |
| Coexpression | GSE28737_WT_VS_BCL6_HET_MARGINAL_ZONE_BCELL_DN | 1.57e-03 | 200 | 8 | 2 | M9344 | |
| Coexpression | GSE3982_DC_VS_TH2_UP | 1.57e-03 | 200 | 8 | 2 | M5484 | |
| Coexpression | GSE5099_UNSTIM_VS_MCSF_TREATED_MONOCYTE_DAY7_DN | 1.57e-03 | 200 | 8 | 2 | M6585 | |
| Coexpression | GSE26495_NAIVE_VS_PD1LOW_CD8_TCELL_DN | 1.57e-03 | 200 | 8 | 2 | M4659 | |
| Coexpression | GSE26495_NAIVE_VS_PD1HIGH_CD8_TCELL_DN | 1.57e-03 | 200 | 8 | 2 | M4656 | |
| Coexpression | BERTUCCI_MEDULLARY_VS_DUCTAL_BREAST_CANCER_UP | 1.68e-03 | 207 | 8 | 2 | M14539 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c03-GZMK|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.77e-06 | 167 | 8 | 3 | abc4ba308ca3be41b0da604f5d82579fd58dff7b | |
| ToppCell | 5'-Adult-LargeIntestine-Hematopoietic-T_cells-Th17|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.82e-06 | 168 | 8 | 3 | 97bf074b91c9ae0064edc31fa4a2658ffdcfefa3 | |
| ToppCell | (1)_T_cells-(1)_T_regulatory|(1)_T_cells / Lung cell shreds - cell class (v4) and cell subclass (v4) | 3.71e-06 | 184 | 8 | 3 | 3cbf81757653652441843d85cb7ec1dcf25ca1b0 | |
| ToppCell | TCGA-Thryoid-Primary_Tumor-Thyroid_Papillary_Carcinoma-Follicular-3|TCGA-Thryoid / Sample_Type by Project: Shred V9 | 1.38e-04 | 101 | 8 | 2 | d0c004d66ba847588a78d5c5c85e82e9e94d0e30 | |
| ToppCell | COVID-19-kidney-Epithelial_(Imm)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.92e-04 | 119 | 8 | 2 | 7cde7c73bb71f5e1911706e51c2ea6dcc72930ac | |
| ToppCell | COVID-19-kidney-Epithelial_(Imm)|kidney / Disease (COVID-19 only), tissue and cell type | 1.95e-04 | 120 | 8 | 2 | e17c85d41c781a29dec7e03a8b0637dccb4346bc | |
| ToppCell | PBMC-Mild-cDC_4|Mild / Compartment, Disease Groups and Clusters | 2.40e-04 | 133 | 8 | 2 | e53fbd69775a4bff61de82557342f7ac80915c4d | |
| ToppCell | E16.5-samps-Mesenchymal-Matrix_fibroblast-_fetal-Intermediate_Fibroblast|E16.5-samps / Age Group, Lineage, Cell class and subclass | 2.55e-04 | 137 | 8 | 2 | dd5364a1002650d21e0c83d8c701b5f7b09d1c19 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Myeloid-Granulocytic-Neutrophil-Neu_c4-RSAD2|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.70e-04 | 141 | 8 | 2 | b5e85f89b930a0ec70cc95733c5ab76ac3e9497f | |
| ToppCell | E18.5-samps-Mesenchymal-Myofibroblast-MyoFB-1|E18.5-samps / Age Group, Lineage, Cell class and subclass | 2.85e-04 | 145 | 8 | 2 | ac41c6c02b7d78162b86222983688f54d04ac47d | |
| ToppCell | IIH-CD4-CD4_Treg|IIH / Condition, Cell_class and T cell subcluster | 3.17e-04 | 153 | 8 | 2 | 28fb5d9f66f58741a5d43df004f80da3d910682e | |
| ToppCell | 5'-GW_trimst-1-SmallIntestine-Mesenchymal-immature_mesenchymal_cell-Mesoderm_2_(ZEB2+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.30e-04 | 156 | 8 | 2 | d411116d54add2d4fe649a97ac54cb94c085312f | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Hematopoietic-T_cells-ILC3|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.51e-04 | 161 | 8 | 2 | 584e44e6048c2678eb72cd23a86f48f2466c5da4 | |
| ToppCell | 10x_3'_v3-lymph_node_(10x_3'_v3)-myeloid-myeloid_dendritic-mature_conventional_dendritic_cell|lymph_node_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 3.96e-04 | 171 | 8 | 2 | d934d68efc5739483c735dc702ccd30b07a6aa7e | |
| ToppCell | 3'-Child09-12-SmallIntestine-Hematopoietic-T_cells-Th1|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.01e-04 | 172 | 8 | 2 | c0c9a3f5b5fb942b049bc159fd9f21b5b706edd2 | |
| ToppCell | Multiple_Sclerosis-Lymphocyte-T_NK-MAIT|Multiple_Sclerosis / Disease, Lineage and Cell Type | 4.01e-04 | 172 | 8 | 2 | 18bda0038cb37da6784e7bf7291272c108cfd9c5 | |
| ToppCell | 10x5'-blood-Lymphocytic_Invariant-Inducer-like-MAIT|blood / Manually curated celltypes from each tissue | 4.15e-04 | 175 | 8 | 2 | b4e4b66e89f79999768a6192c8404cb2465f920b | |
| ToppCell | 3'_v3-lymph-node_spleen-Lymphocytic_Invariant-Inducer-like-MAIT|lymph-node_spleen / Manually curated celltypes from each tissue | 4.20e-04 | 176 | 8 | 2 | 25c197d3b39deffa4801a1d12cdb54320cbae509 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Hematopoietic-T_cells-LTi-like_NCR+_ILC3|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.29e-04 | 178 | 8 | 2 | 0b59e3d75b143bd7bf91a7800a49699c51e68c5a | |
| ToppCell | 5'-Adult-LargeIntestine-Hematopoietic-T_cells-MAIT_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.29e-04 | 178 | 8 | 2 | f52f837e948deb6a2d031325f49891bca8d375da | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Hematopoietic-T_cells-LTi-like_NCR+_ILC3|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.53e-04 | 183 | 8 | 2 | d4a558bc0b8e11be195a7da1468ab38eb477117d | |
| ToppCell | COVID-19_Severe-gd_T|COVID-19_Severe / Disease condition and Cell class | 4.58e-04 | 184 | 8 | 2 | 791f1bcb954aadc63d4117c400537d036f68734d | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Hematopoietic-T_cells-Th1|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.63e-04 | 185 | 8 | 2 | 326c8b6ea0e9140616d7b867db1385b980dc3678 | |
| ToppCell | Control-Lymphoid-CD8_T_cells|Lymphoid / Condition, Lineage and Cell class | 4.68e-04 | 186 | 8 | 2 | a8a4c0f4058f5bbc435dd2dd41d55383173a1358 | |
| ToppCell | ILEUM-inflamed-(1)_Cytotoxic_CD8_Trm|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 4.78e-04 | 188 | 8 | 2 | d26894d1066a70e4b32ae41fff1c4718f2591ba9 | |
| ToppCell | ILEUM-inflamed-(1)_T_cell-(1)_Cytotoxic_CD8_Trm|(1)_T_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 4.78e-04 | 188 | 8 | 2 | c80956649b10b7dd7540394a00fc2a0619b27e80 | |
| ToppCell | T_cells-GZMK+_CD8+_T_cells|World / Immune cells in Kidney/Urine in Lupus Nephritis | 4.83e-04 | 189 | 8 | 2 | e2ca075aedf7c370ab4ede6272254ffd06cbcdec | |
| ToppCell | 10x5'-bone_marrow-Lymphocytic_Invariant-Inducer-like|bone_marrow / Manually curated celltypes from each tissue | 4.83e-04 | 189 | 8 | 2 | ac2995e599f3d1813218479dc515b1d612c0ef8b | |
| ToppCell | mild-Myeloid-Immature_Neutrophils_1|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 4.83e-04 | 189 | 8 | 2 | 94dd5d4d815449feff7ce157fe7f8234f7c81422 | |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_Invariant-Inducer-like-MAIT|lymph-node_spleen / Manually curated celltypes from each tissue | 4.83e-04 | 189 | 8 | 2 | afe3a4fe7c10eeeb7064129778d940269c9acbef | |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_Invariant-Inducer-like|lymph-node_spleen / Manually curated celltypes from each tissue | 4.89e-04 | 190 | 8 | 2 | 0c7eb8f4f2926af01bf44d5c9f239be7b81c67fe | |
| ToppCell | 10x5'v1-week_17-19-Lymphocytic_NK-T_NK-CD56_bright_NK|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 4.89e-04 | 190 | 8 | 2 | 251d50a77e5118a9ad19ea01a7c7c862230ed63c | |
| ToppCell | 10x_3'_v3-spleen_(10x_3'_v3)-myeloid-myeloid_monocytic-intermediate_monocyte|spleen_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 4.89e-04 | 190 | 8 | 2 | 896b5825edb30fe62cbbed6078570c1f8057a99e | |
| ToppCell | metastatic_Lymph_Node-T/NK_cells-Treg|metastatic_Lymph_Node / Location, Cell class and cell subclass | 4.89e-04 | 190 | 8 | 2 | 0523f1039b39a45a23f2f4444e5b47ed581fc4bb | |
| ToppCell | metastatic_Lymph_Node-T/NK_cells-Exhausted_CD8+_T|metastatic_Lymph_Node / Location, Cell class and cell subclass | 4.89e-04 | 190 | 8 | 2 | cb4cf8ae2156c20b7978ae2e55aa605b4e90f455 | |
| ToppCell | 10x5'-bone_marrow-Lymphocytic_Invariant-Inducer-like-MAIT|bone_marrow / Manually curated celltypes from each tissue | 4.94e-04 | 191 | 8 | 2 | 7a28905ad504979497836e87df81d529e675ce78 | |
| ToppCell | 3'-Child09-12-SmallIntestine-Hematopoietic-T_cells-Th17|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.94e-04 | 191 | 8 | 2 | b3ed4797a7a9810cf3507e0d0f23f45c35bd8ba2 | |
| ToppCell | ILEUM-non-inflamed-(1)_Cytotoxic_CD8_Trm|non-inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 4.99e-04 | 192 | 8 | 2 | cc9287803cd979e4b81f0649527f1b3bf54d0b83 | |
| ToppCell | PBMC-Severe-Myeloid-Neutrophil-immature_Neutrophil-Neu_4|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.04e-04 | 193 | 8 | 2 | ccab6a0c76f574ef7e1d6d5f1e620376daf21bbf | |
| ToppCell | NS-moderate-d_07-13-Lymphoid-Treg|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 5.04e-04 | 193 | 8 | 2 | 6115d43017070a78d335687bd039c08f00f77029 | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Hematopoietic-T_cells-LTi-like_NCR-_ILC3|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.04e-04 | 193 | 8 | 2 | d8e6a7f1da4506acaa06380b4aec3fe299ec8b7e | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Stem-like-NPC-like-NPC-like_neural-F|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.04e-04 | 193 | 8 | 2 | 088c8b1e968f5356502347eaabdc6b1b1d4befd0 | |
| ToppCell | normal_Pleural_Fluid-T/NK_cells-Exhausted_CD8+_T|normal_Pleural_Fluid / Location, Cell class and cell subclass | 5.09e-04 | 194 | 8 | 2 | 68a9e00c9e1a855eeebfc26c038652f3800758db | |
| ToppCell | (1)_T_cells-(1)_T_CD8_activated|(1)_T_cells / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 5.09e-04 | 194 | 8 | 2 | e3f288b58525c1f34db4459d3e83e0df695adfc7 | |
| ToppCell | BLOOD--(1)_MAIT-like_CD8_T_cells| / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 5.09e-04 | 194 | 8 | 2 | 0064bcd9ac2fecec81f8d4e7d9f86f0089872fe7 | |
| ToppCell | PBMC-Severe-Myeloid-Neutrophil-immature_Neutrophil-Neu_4|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 5.09e-04 | 194 | 8 | 2 | 23318a1b55895b5166c6151f488a94a09b4627ff | |
| ToppCell | Control-MAIT|Control / Disease condition and Cell class | 5.09e-04 | 194 | 8 | 2 | ed99f8bff6766795fc396990604366f49ff58181 | |
| ToppCell | ILEUM-non-inflamed-(1)_T_cell-(1)_Cytotoxic_CD8_Trm|(1)_T_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 5.09e-04 | 194 | 8 | 2 | 094e8dfe640c7cca410b85f93063ea0bd7e861cf | |
| ToppCell | 5'-Adult-LargeIntestine-Hematopoietic-T_cells-TRGV2_gdT|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.09e-04 | 194 | 8 | 2 | 4b208bb429a1e3d58a9b757b05ef4df85a1e7f1e | |
| ToppCell | normal_Pleural_Fluid-T/NK_cells-CD8_low_T|normal_Pleural_Fluid / Location, Cell class and cell subclass | 5.09e-04 | 194 | 8 | 2 | 11eb317f66cbced1cedadd6daba443c4d832c49f | |
| ToppCell | BLOOD--(1)_T_cell-(1)_MAIT-like_CD8_T_cells|(1)_T_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 5.09e-04 | 194 | 8 | 2 | 830342a4df39c24c30fb4746ce762af697716148 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Hematopoietic-T_cells-LTi-like_NCR+_ILC3|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.14e-04 | 195 | 8 | 2 | 69201b1172bcf0999c726516e4d30863afceab0b | |
| ToppCell | (1)_T_CD8_MAIT|World / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 5.20e-04 | 196 | 8 | 2 | 5fc99a8e3dde12fd0b0b2e0a2db48ac16b42739e | |
| ToppCell | critical-Lymphoid-CTL|Lymphoid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 5.20e-04 | 196 | 8 | 2 | c861f017aa9050282aa81c5a445bae399df00e4f | |
| ToppCell | Control-Neu_4|Control / 5 Neutrophil clusters in COVID-19 patients | 5.20e-04 | 196 | 8 | 2 | b8b7b54ca17a08fa775507bb22b1c7248ada8f40 | |
| ToppCell | (2)_NK/T-(220)_CD8+_Cytotoxic_T_cell|(2)_NK/T / immune cells in Peripheral Blood (logTPM normalization) | 5.20e-04 | 196 | 8 | 2 | d123361c32bcd2329200f0316bc5b54bb494e92d | |
| ToppCell | (1)_T_cells-(1)_T_CD8_MAIT|(1)_T_cells / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 5.25e-04 | 197 | 8 | 2 | 0f01907d62c9c08cb54fe66c038f0adf7093e3c6 | |
| ToppCell | normal_Pleural_Fluid-T/NK_cells-Exhausted_CD8+_T|T/NK_cells / Location, Cell class and cell subclass | 5.25e-04 | 197 | 8 | 2 | 2bf540fa228687a71f595a807e4a2af20588a82c | |
| ToppCell | (2)_NK/T-(22)_CD8+_T_cell|(2)_NK/T / immune cells in Peripheral Blood (logTPM normalization) | 5.25e-04 | 197 | 8 | 2 | 20dad8e4ed36a0185e231ddcb327725d2b2005e0 | |
| ToppCell | (2)_NK/T-(22)_CD8+_T_cell-(220)_CD8+_Cytotoxic_T_cell|(22)_CD8+_T_cell / immune cells in Peripheral Blood (logTPM normalization) | 5.30e-04 | 198 | 8 | 2 | 1bb60688ff0e42471c8b646652fe95b9b28c41a3 | |
| ToppCell | control-MAIT|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 5.30e-04 | 198 | 8 | 2 | 13955a4026c97e11d94973ac87bf018f64a2616c | |
| ToppCell | severe|World / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 5.36e-04 | 199 | 8 | 2 | c24aacef7405700bc5d0b736a38feea12b7f17c8 | |
| ToppCell | MS-IIF-Lymphocyte-T/NK-CD4+_Tem|IIF / Disease, condition lineage and cell class | 5.36e-04 | 199 | 8 | 2 | a876d53a9cc5d1584bed5ff679be8f5273daad37 | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Lymphoid-CD4/CD8-CD8_cytotoxic|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.36e-04 | 199 | 8 | 2 | 8f2b57cf2f932f20ea029132d8bda01aac774571 | |
| ToppCell | LPS_only-Mesenchymal_fibroblastic-Fibroblasts-Proliferative_MatrixFB|LPS_only / Treatment groups by lineage, cell group, cell type | 5.36e-04 | 199 | 8 | 2 | eb5971660dff356721a004f821d52a5b7a33c951 | |
| ToppCell | MS-Multiple_Sclerosis-Lymphocyte-T/NK-MAIT|Multiple_Sclerosis / Disease, condition lineage and cell class | 5.41e-04 | 200 | 8 | 2 | 10120f474ac3de10fc8e66158969415bd3f8c1da | |
| ToppCell | control-MAIT|control / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 5.41e-04 | 200 | 8 | 2 | aeea4bda2e38cc6db571ed2b47ce022d637619bd | |
| ToppCell | Control-Control-Lymphocyte-T/NK-MAIT|Control / Disease, condition lineage and cell class | 5.41e-04 | 200 | 8 | 2 | 888a8045e0457cd9d0c570360cca20a6efb44f13 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| WWNLNIHVHAPPVQP | 571 | Q5W0A0 | |
| VMPPIPRHETWVVGW | 56 | Q5VT40 | |
| MAMPHWLRHLVPGPW | 236 | O15528 | |
| QLPSHWARHSPWPMA | 376 | Q6B0I6 | |
| WCVPHPNWPNHTLVL | 81 | Q96PP8 | |
| HDPNMTHPEFLILWW | 236 | P46976 | |
| IDWFMPWPPQALHAV | 2956 | Q8IVF4 | |
| APDHWWMEAPHHWLP | 81 | Q8N377 | |
| PLTDTVPIHSWIHPW | 541 | Q9UBB9 | |
| VPIHSWIHPWLPLMQ | 546 | Q9UBB9 | |
| WIHPWLPLMQARLEP | 551 | Q9UBB9 |